Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy

Clinical trial NCT00848354 · COMPLETED

Trial details

NCT number: NCT00848354
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2009-06-01
Primary completion: 2013-04-01
Enrollment: 429

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.